New research indicates that individuals who discontinue popular slimming jabs like Mounjaro or Wegovy tend to recover shed pounds at a significantly accelerated pace than those who halt traditional diet and exercise plans.
Published data in a leading health publication points out that while obese people frequently drop substantial amounts of their body weight while using the jabs, the weight returns at an estimated rate of 0.8 kg per month once they quit.
"Users purchasing such drugs should be cognizant of the potential of fast weight regain when the therapy ends," stated lead investigator Dr. Susan Jebb.
Such speed of regain means a return to starting mass in about a year and a half.
Analyzing Treatments
The analysis, which looked at dozens of trials involving over 9,000 of participants, contrasted the results of GLP-1 agonists with conventional dieting.
The team note that individuals who shed pounds through diet and exercise typically have a slower creep back—around 100 grams monthly—after stopping.
Understanding the Quick Regain
Doctors believe the mechanism of the injections is key to understanding the amplified weight return.
The injections copy a natural hormone called GLP-1, which moderates appetite.
"Artificially providing GLP-1 concentrations several times higher than the body's typical production might result in the system to generate a reduced amount of its endogenous hormone, and could reduce sensitivity to its effects," said Dr. Adam Collins, a nutrition researcher.
"Withdrawal of this GLP-1 'fix' means appetite is unsuppressed, making overeating a significant risk."
A Chronic Disease?
Health authorities advise the injections for people with obesity-related health risks, alongside prescribed diet and exercise modifications.
Professionals contend that, considering the significant potential of relapse, the therapy is often life-long.
This opinion is reinforced by pharmaceutical companies, who state that the findings "underscore the chronic character of obesity," akin to managing conditions like diabetes.
User Accounts
Individuals who have stopped the medication explain a sudden return of appetite.
"It felt as if a switch flipping and I was suddenly extremely hungry," described an individual.
This difficulty is exacerbated if users have not developed sustainable dietary or behavioural changes during therapy.
Widespread Use
Recent estimates show that millions of adults in the UK have used these injections in the last 12 months, with desire continuing to grow.
- Use is higher among women compared to males.
- The middle-aged age group shows the highest usage rates.
- Many obtain the medications through private healthcare rather than the NHS.
Finally, clinicians stress that while GLP-1 drugs are effective agents for weight loss, they are not a magic fix and long-term success hinges on combined lifestyle management.
